Daily News Podcast

Updated anthrax vaccine recommendations

Publish date: July 2, 2018

 

The advisory committee on Immunization Practices voted to approve recommendations for the use of Anthrax Vaccine Adsorbed (AVA) in post-exposure prophylaxis (PEP) in the event of a wide-area release of Bacillus anthracis spores. Also today, the FDA approves topical anticholinergic for primary axillary hyperhidrosis, a shortage of ob.gyns. looms, and more Americans missed care in 2017 as a result of cost.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Clostridium difficile Colitis in a Patient With Abdominal Distention, Pain, and Severe Constipation
MDedge Family Medicine
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Family Medicine
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Family Medicine
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Family Medicine
Patients going without as insulin prices skyrocket
MDedge Family Medicine
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Family Medicine
Opioids do more harm than good for musculoskeletal pain
MDedge Family Medicine
Addiction: Veterans with pain, opioid use disorder
MDedge Family Medicine
Anthrax vaccine recommendations updated in the event of a wide-area release
MDedge Family Medicine
Medicare beneficiaries are dying differently
MDedge Family Medicine